List of Tables:
Table 1. Snapshot of North America In Vitro Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in North America In Vitro Diagnostics Market 35
Table 6. North America In Vitro Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. North America In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn 45
Table 8. North America In Vitro Diagnostics Market by Technology, 2021-2031, $ mn 50
Table 9. North America In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn 61
Table 10. North America In Vitro Diagnostics Market by Application, 2021-2031, $ mn 67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022 70
Table 12. North America In Vitro Diagnostics Market by End User, 2021-2031, $ mn 87
Table 13. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn 95
Table 14. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn 99
Table 15. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 99
Table 16. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn 99
Table 17. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn 101
Table 18. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 101
Table 19. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn 101
Table 20. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn 103
Table 21. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 103
Table 22. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn 103
Table 23. Abbott Laboratories, Inc.: Company Snapshot 108
Table 24. Abbott Laboratories, Inc.: Business Segmentation 109
Table 25. Abbott Laboratories, Inc.: Product Portfolio 109
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America In Vitro Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America In Vitro Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of North America In Vitro Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porters Fiver Forces Analysis of North America In Vitro Diagnostics Market 39
Figure 13. Breakdown of North America In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. North America In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 45
Figure 16. North America In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 46
Figure 17. North America In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 47
Figure 18. North America In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 48
Figure 19. North America In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 49
Figure 20. Breakdown of North America In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 21. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 22. North America In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 52
Figure 23. North America In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 53
Figure 24. North America In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 54
Figure 25. North America In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 55
Figure 26. North America In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 56
Figure 27. North America In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 57
Figure 28. North America In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 58
Figure 29. North America In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 59
Figure 30. North America In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 60
Figure 31. Breakdown of North America In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 62
Figure 32. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 62
Figure 33. North America In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 63
Figure 34. North America In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 64
Figure 35. North America In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 65
Figure 36. North America In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 66
Figure 37. Breakdown of North America In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 68
Figure 38. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 68
Figure 39. North America In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 69
Figure 40. North America In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 79
Figure 41. North America In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 80
Figure 42. North America In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 81
Figure 43. North America In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 82
Figure 44. North America In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 83
Figure 45. North America In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 84
Figure 46. North America In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 85
Figure 47. North America In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 86
Figure 48. Breakdown of North America In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 88
Figure 49. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 88
Figure 50. North America In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 89
Figure 51. North America In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 90
Figure 52. North America In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 91
Figure 53. North America In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 92
Figure 54. North America In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 93
Figure 55. Breakdown of North America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 95
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57. U.S. In Vitro Diagnostics Market, 2021-2031, $ mn 98
Figure 58. Canada In Vitro Diagnostics Market, 2021-2031, $ mn 100
Figure 59. In Vitro Diagnostics Market in Mexico, 2021-2031, $ mn 102
Figure 60. Growth Stage of North America In Vitro Diagnostics Industry over the Forecast Period 104
